Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China
· Delayed Price · Currency is CNY
70.68
+3.38 (5.02%)
Jan 3, 2025, 3:00 PM CST
Beijing Wantai Biological Pharmacy Enterprise Revenue
Beijing Wantai Biological Pharmacy Enterprise had revenue of 582.07M CNY in the quarter ending September 30, 2024, a decrease of -27.72%. This brings the company's revenue in the last twelve months to 2.49B, down -66.82% year-over-year. In the year 2023, Beijing Wantai Biological Pharmacy Enterprise had annual revenue of 5.51B, down -50.73%.
Revenue (ttm)
2.49B
Revenue Growth
-66.82%
P/S Ratio
35.88
Revenue / Employee
647.93K
Employees
3,843
Market Cap
89.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.51B | -5.67B | -50.73% |
Dec 31, 2022 | 11.19B | 5.43B | 94.51% |
Dec 31, 2021 | 5.75B | 3.40B | 144.25% |
Dec 31, 2020 | 2.35B | 1.17B | 98.88% |
Dec 31, 2019 | 1.18B | 201.07M | 20.46% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.93B |
Shanghai Pharmaceuticals Holding | 272.42B |